Despite the evidence that PD-L1 expression in other tumor cells results in functional NK cell impairment [187] and that CLL cells express high levels of PD-L1 [182,188], the involvement of the PD-1/PD-L1 axis in regulating NK cell functions in CLL patients remains to be defined. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.